These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 622092)
1. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. Anturane Reinfarction Trial Research Group N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942 [TBL] [Abstract][Full Text] [Related]
2. The anturane reinfarction trial. Sherry S Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382 [TBL] [Abstract][Full Text] [Related]
3. Sulfinpyrazone after myocardial infarction: no decision yet. Relman AS N Engl J Med; 1980 Dec; 303(25):1476-7. PubMed ID: 7432408 [No Abstract] [Full Text] [Related]
4. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct]. Foz M Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709 [No Abstract] [Full Text] [Related]
5. New job for an old drug? Relman AS N Engl J Med; 1978 Feb; 298(6):333-4. PubMed ID: 622092 [No Abstract] [Full Text] [Related]
6. Cardiac death prevention in post-myocardial infarction patients: a review. Boissel JP; Leizorovicz A; Faucomprez C Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625 [No Abstract] [Full Text] [Related]
9. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery. Cairns JA Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983 [No Abstract] [Full Text] [Related]
10. Antiplatelet agents: their role in the prevention of sudden death. Hirsh J Ann N Y Acad Sci; 1982; 382():289-304. PubMed ID: 7044244 [No Abstract] [Full Text] [Related]
11. Role of platelet-active drugs in coronary artery disease. Sherry S Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025 [No Abstract] [Full Text] [Related]